JIANGSU HANSEN PHARMACEUTICAL CO., LTD ( China (Mainland))

JIANGSU HANSEN PHARMACEUTICAL CO., LTD, founded in July 1995, is one of the top 10 pharmaceutical manufacturers of China with the headquarter and manufacturing base in New Medicine Industry Park, Lianyungang. Hansoh is engaged in the research, development and manufacture of new generic drugs which cover four therapeutic categories – anticancer, anti-diabetics, central nervous system (CNS) and gastro-intestinal. The company has clinical research centers and innovative drugs R & D centers in Beijing and Shanghai.

The quality system complies with the strict regulatory requirements of leading health authorities. In 2005, all the APIs and Formulation drugs were granted cGMP certificates by China SFDA. In October 2008, Vinorelbine Tartrate was passed Japan PMDA’s Inspection. Vinorelbine Tartrate (CAS NO.125317-39-7) and Gemcitabine Hydrochloride with CAS registry number of 122111-03-9 have been inspected and approved by US FDA. Currently, Hansoh has filed more than 40 intellectual properties and 7 granted.